170 related articles for article (PubMed ID: 30879795)
1. Predictive factors of upstaging DCIS to invasive carcinoma in BCT vs mastectomy.
Sheaffer WW; Gray RJ; Wasif N; Stucky CC; Cronin PA; Kosiorek HE; Basu A; Pizzitola VJ; Patel B; Giurescu ME; Lorans R; McCullough AE; Ocal IT; Pockaj BA
Am J Surg; 2019 Jun; 217(6):1025-1029. PubMed ID: 30879795
[TBL] [Abstract][Full Text] [Related]
2. Predictors of treatment with mastectomy, use of sentinel lymph node biopsy and upstaging to invasive cancer in patients diagnosed with breast ductal carcinoma in situ (DCIS) on core biopsy.
Chin-Lenn L; Mack LA; Temple W; Cherniak W; Quinn RR; Ravani P; Lewin AM; Quan ML
Ann Surg Oncol; 2014 Jan; 21(1):66-73. PubMed ID: 24046105
[TBL] [Abstract][Full Text] [Related]
3. Upstaging to invasive ductal carcinoma after mastectomy for ductal carcinoma in situ: predictive factors and role of sentinel lymph node biopsy.
Watanabe Y; Anan K; Saimura M; Koga K; Fujino M; Mine M; Tamiya S; Nishihara K; Nakano T; Mitsuyama S
Breast Cancer; 2018 Nov; 25(6):663-670. PubMed ID: 29786772
[TBL] [Abstract][Full Text] [Related]
4. Multicentre study of the risk of invasive cancer and use of sentinel node biopsy in women with a preoperative diagnosis of ductal carcinoma in situ.
Munck F; Clausen EW; Balslev E; Kroman N; Tvedskov TF; Holm-Rasmussen EV
Br J Surg; 2020 Jan; 107(1):96-102. PubMed ID: 31823362
[TBL] [Abstract][Full Text] [Related]
5. Necessity of sentinel lymph node biopsy in ductal carcinoma in situ patients: a retrospective analysis.
Shin YD; Lee HM; Choi YJ
BMC Surg; 2021 Mar; 21(1):159. PubMed ID: 33752671
[TBL] [Abstract][Full Text] [Related]
6. Sentinel node biopsy in ductal carcinoma in situ of the breast: Never justified?
Sorrentino L; Sartani A; Bossi D; Amadori R; Nebuloni M; Truffi M; Bonzini M; Riggio E; Foschi D; Corsi F
Breast J; 2018 May; 24(3):325-333. PubMed ID: 29024241
[TBL] [Abstract][Full Text] [Related]
7. Does sentinel lymph node biopsy for screening high-grade ductal carcinoma in situ of the breast cause more harm than good?
Ramzi S; Najeeb E; Coulthard J; Jenkins S
Breast Cancer Res Treat; 2020 Jul; 182(1):47-54. PubMed ID: 32430678
[TBL] [Abstract][Full Text] [Related]
8. Axillary evaluation is not warranted in patients preoperatively diagnosed with ductal carcinoma in situ by core needle biopsy.
Si J; Guo R; Huang N; Xiu B; Zhang Q; Chi W; Wu J
Cancer Med; 2019 Dec; 8(18):7586-7593. PubMed ID: 31660702
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision.
Kim J; Han W; Lee JW; You JM; Shin HC; Ahn SK; Moon HG; Cho N; Moon WK; Park IA; Noh DY
Breast; 2012 Oct; 21(5):641-5. PubMed ID: 22749854
[TBL] [Abstract][Full Text] [Related]
10. Prediction of underestimated invasiveness in patients with ductal carcinoma in situ of the breast on percutaneous biopsy as rationale for recommending concurrent sentinel lymph node biopsy.
Schulz S; Sinn P; Golatta M; Rauch G; Junkermann H; Schuetz F; Sohn C; Heil J
Breast; 2013 Aug; 22(4):537-42. PubMed ID: 23237921
[TBL] [Abstract][Full Text] [Related]
11. A model to predict upstaging to invasive carcinoma in patients preoperatively diagnosed with ductal carcinoma in situ of the breast.
Kondo T; Hayashi N; Ohde S; Suzuki K; Yoshida A; Yagata H; Niikura N; Iwamoto T; Kida K; Murai M; Takahashi Y; Tsunoda H; Nakamura S; Yamauchi H
J Surg Oncol; 2015 Oct; 112(5):476-80. PubMed ID: 26346047
[TBL] [Abstract][Full Text] [Related]
12. Sentinel Node Procedure Obsolete in Lumpectomy for Ductal Carcinoma In Situ.
Heymans C; van Bastelaar J; Visschers RGJ; Vissers YLJ
Clin Breast Cancer; 2017 Jun; 17(3):e87-e93. PubMed ID: 28162949
[TBL] [Abstract][Full Text] [Related]
13. Value of sentinel lymph node biopsy in breast ductal carcinoma in situ upstaged to invasive carcinoma.
Sakr R; Antoine M; Barranger E; Dubernard G; Salem C; Daraï E; Uzan S
Breast J; 2008; 14(1):55-60. PubMed ID: 18186866
[TBL] [Abstract][Full Text] [Related]
14. The Role of Sentinel Lymph Node Biopsy and Factors Associated with Invasion in Extensive DCIS of the Breast Treated by Mastectomy: The Cinnamome Prospective Multicenter Study.
Tunon-de-Lara C; Chauvet MP; Baranzelli MC; Baron M; Piquenot J; Le-Bouédec G; Penault-Llorca F; Garbay JR; Blanchot J; Mollard J; Maisongrosse V; Mathoulin-Pélissier S; MacGrogan G
Ann Surg Oncol; 2015 Nov; 22(12):3853-60. PubMed ID: 25777085
[TBL] [Abstract][Full Text] [Related]
15. A Validated Nomogram to Predict Upstaging of Ductal Carcinoma in Situ to Invasive Disease.
Jakub JW; Murphy BL; Gonzalez AB; Conners AL; Henrichsen TL; Maimone S; Keeney MG; McLaughlin SA; Pockaj BA; Chen B; Musonza T; Harmsen WS; Boughey JC; Hieken TJ; Habermann EB; Shah HN; Degnim AC
Ann Surg Oncol; 2017 Oct; 24(10):2915-2924. PubMed ID: 28766196
[TBL] [Abstract][Full Text] [Related]
16. Ductal carcinoma in situ: value of sentinel lymph node biopsy.
Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S
J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457
[TBL] [Abstract][Full Text] [Related]
17. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ
Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346
[TBL] [Abstract][Full Text] [Related]
18. Is Sentinel Lymph Node Biopsy Required for a Core Biopsy Diagnosis of Ductal Carcinoma In Situ with Microinvasion?
Flanagan MR; Stempel M; Brogi E; Morrow M; Cody HS
Ann Surg Oncol; 2019 Sep; 26(9):2738-2746. PubMed ID: 31147995
[TBL] [Abstract][Full Text] [Related]
19. Sentinel lymph node positivity in patients undergoing mastectomies for ductal carcinoma in situ (DCIS).
Price A; Schnabel F; Chun J; Kaplowitz E; Goodgal J; Guth A; Axelrod D; Shapiro R; Mema E; Moy L; Darvishian F; Roses D
Breast J; 2020 May; 26(5):931-936. PubMed ID: 31957944
[TBL] [Abstract][Full Text] [Related]
20. Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy.
Tunon-de-Lara C; Giard S; Buttarelli M; Blanchot J; Classe JM; Baron M; Monnier B; Houvenaeghel G
Breast J; 2008; 14(2):135-40. PubMed ID: 18315691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
